Ligustrazine attenuates acute myocardium injury after thermal trauma

Burns

Volumn 33, Issue 3, 2007, Pages 321-327

  Gao, Shan ^a   Chen, Zhi Wu ^a   Zheng, Hong ^a   Chen, Xu Lin ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

ATP; Burn; Full thickness burn; Ligustrazine; Myocardium injury; Organ failure; Rat; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; RINGER LACTATE SOLUTION; TETRAMETHYLPYRAZINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID RESUSCITATION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEDICAL ASSESSMENT; NONHUMAN; RAT; RESUSCITATION; SCORING SYSTEM; SPRAGUE DAWLEY RAT; THERMAL INJURY; ULTRASTRUCTURE; UPREGULATION; WATER CONTENT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BURNS; HEART INJURIES; MYOCARDIUM; MYOCYTES, CARDIAC; PYRAZINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS; WATER;

EID: 33947277261     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2006.07.002     Document Type: Article

References (36)

1. McGwin G., Cross J.M., Ford J.W., and Rue L.W. Long-term trends in mortality according to age among adult burn patients. J Burn Care Rehabil 24 (2003) 21-25
2. Muller M.J., Pegg S.P., and Rule M.R. Determinants of death following burn injury. Br J Surg 88 (2001) 583-587
3. Ryan C.M., Schoenfield D.A., Thorpe W.P., Sheridan R.J., Cassem E.H., and Tompkins R.G. Objective estimates of the probability of death from burn injuries. New Engl J Med 338 (1998) 362-366
4. Wolf S.R., Rose J.K., Desai M.H., Mileski J.P., Barrow R.E., and Herndon D.N. Mortality determinants in massive pediatric burns. An analysis of 103 children with < or =80% TBSA burns (> or =70% full-thickness). Ann Surg 225 (1997) 554-569
5. Horton J.W., Garcia N.M., White D.J., and Keffer J. Postburn cardiac contractile function and biochemical markers of postburn cardiac injury. J Am Coll Surg 181 (1995) 289-298
6. Mueller M., Sartorelli K., DeMueles J.E., and Gameilli R.L. Effects of fluid resuscitation on cardiac dysfunction following thermal injury. J Surg Res 44 (1988) 745-753
7. Adams H.R., Baxter C.R., and Izenberg S.D. Decreased contractibility and compliance of the left ventricle as complications of thermal trauma. Am Heart J 108 (1984) 1477-1487
8. Cain B.S., Harken A.H., and Meldrum D.R. Therapeutic strategies to reduce TNF-α mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol 31 (1999) 931-947
9. Cain B.S., Meldrum D.R., Dinarello C.A., Meng X., Joo K.S., Banergee A., et al. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function. Crit Care Med 27 (1999) 1309-1318
10. Kumar A., Thota V., Dee L., Olson J., Uretz E., and Parillo J.E. Tumor necrosis factor-alpha and interleukin 1-beta are responsible for the in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996) 949-958
11. Oral H., Dorn G.W., and Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272 (1997) 4836-4842
12. Horton J.W., Maass D., White J., and Sanders B. Hypertonic saline dextran suppresses burn-related cytokine secretion by cardiomyocytes. Am J Physiol Heart Circ Physiol 280 (2001) 1591-1601
13. Abraham E., Glauser M.P., Butler T., Barbino J., Gelmont D., Laterre P.F., et al. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277 (1997) 1531-1538
14. Abraham E., Wunderink R., Silverman H., Perl T.M., Nasraway S., Levy H., et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 273 (1995) 934-941
15. Cain B.S., Meldrum D.R., Meng X., Dinarello C.A., Shames B.O., Banerjee A., et al. p38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function. J Surg Res 83 (1999) 7-12
16. Au A.L.S., Kwan Y.W., Kwok C.C., Zhang R.Z., and He G.W. Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery. Eur J Pharmacol 468 (2003) 199-207
17. Zou L.Y., Hao X.M., Zhang G.Q., Zhang M., Guo J.H., and Liu T.F. Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can J Physiol Pharmacol 79 (2001) 621-626
18. Zhou Y., Hu C.P., Deng P.Y., Deng H.W., and Li Y.J. The protective effects of ligustrazine on ischemia-reperfusion and DPPH free radical-induced myocardial injury in isolated rat hearts. Planta Med 70 8 (2004) 818-822
19. Liu C.F., Lin L.T., Ng L.T., and Lin S.C. Hepatoprotective and therapeutic effects of tetramethylpyrazine on econazole-induced liver injury. Planta Med 68 6 (2002) 510-514
20. Zheng H., Chen X.L., Han Z.X., Zhang Z., Wang S.Y., and Xu Q.L. Ligustrazine attenuates acute lung injury after burn trauma. Burns 39 (2005) 635-640
21. Zheng H., Chen X.L., Han Z.X., Wang S.Y., and Chen Z.W. Effect of ligustrazine on liver injury after burn trauma. Burns 31 (2005) [Epublish ahead of print]
22. Chen X.L., Xia Z.F., Ben D.F., Wang G.Q., and Wei D. Role of p38 mitogen activated protein kinase in lung injury after burn trauma. Shock 19 (2003) 475-479
23. Tullson P.C., Whitlock D.M., and Terjung R.L. Adenine nucleotide degradation in slow-twitch red muscle. Am J Physiol Cell Physiol 258 (1990) C258-C265
24. Lu H.Z., Geng B.Q., Zhu Y.L., and Yong D.G. Effects of beta-carotene on doxorubicin-induced cardiotoxicity in rats. Acta Pharmacol Sin 17 (1996) 317-320
25. + exchange. Am J Physiol Heart Circ Physiol 265 (1993) H2017-H2026
26. 23Na-NMR study. J Appl Physiol 91 (2001) 2695-2702
27. Latini R., Bianchi M., Correale E., Dinarello C.A., Fantuzzi G., Fresco C., et al. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin 1 receptor antagonist. J Cardiovasc Pharmacol 23 (1994) 1-6
28. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med 323 (1990) 236-241
29. Horton J.W., Maass D.L., White J., and Sanders B. Hypertonic saline-dextran suppresses burn-related cytokine secretion by cardiomyocytes. Am J Physiol Heart Circ Physiol 280 (2001) H1591-H1601
30. Arras M., Hoche A., Bohle R., Eckert P., Riedel W., and Schaper J. Tumor necrosis factor-alpha in macrophages of heart, liver, kidney, and in the pituitary gland. Cell Tissue Res 285 (1996) 39-49
31. Kapadia S., Lee J., Torre-Amione G., Birdsall H.H., Ma T.S., and Mann D.L. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96 (1995) 1042-1052
32. 2+ transients. FEBS Lett 376 (1995) 24-30
33. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81 (1995) 495-504
34. Chinnaiyan A.M., O'Rourke K., Tewari M., and Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 (1995) 505-512
35. Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., and Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270 (1995) 7795-7798
36. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. New Engl J Med 334 (1996) 1717-1725